Zkusit zdarma
Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

ALNY
Cena:
 
 
Valuace
30
Růst
93
Zdraví
75
preloader

Finanční výsledky Alnylam Pharmaceuticals, Inc. (ALNY)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS2.33-2.18-3.52-9.3-7.2
Gross Profit3032.1M1924.9M1517.9M868.6M704.1M
Net Income Attributable to Common Shareholders313.7M-278.2M-440.2M-1131.2M-852.8M
Operating Profit501.6M-176.9M-282.2M-785.1M-708.7M
Total Revenues3713.9M2248.2M1828.3M1037.4M844.3M